LC-MS

LC-MS stands for Liquid Chromatography - Mass Spectrometry. It is the pairing of a liquid chromatograph, which separates the molecules in a mixture over time, with a mass spectrometer, which measures the mass-to-charge ratio of each molecule as it elutes. The combination is powerful because the chromatograph reduces sample complexity so that the mass spectrometer sees one or a few compounds at a time, while the mass spectrometer provides orthogonal identity information that chromatography alone cannot supply. For synthetic peptide characterization, LC-MS is the standard technique used to confirm that the molecular mass of the main chromatographic peak matches the theoretical mass of the intended sequence.

What LC-MS measures on a peptide

In a typical peptide LC-MS run, the peptide is ionized by electrospray ionization (ESI), producing a distribution of charge states (commonly [M+H]+, [M+2H]2+, [M+3H]3+ for peptides above roughly 1 kDa). Deconvolution of this charge envelope yields the monoisotopic or average mass of the intact peptide, which can be compared to the theoretical mass calculated from the declared sequence. Agreement within a few parts per million on a high-resolution instrument is strong evidence that the main peak has the claimed primary structure. Tandem MS (MS/MS) can then fragment the peptide into b- and y-ions whose mass spacings reconstruct the amino-acid sequence, addressing questions that intact mass alone cannot - for example, distinguishing two sequences that happen to share the same molecular formula. A useful technical overview of ESI charge-state interpretation and peptide deconvolution is Mann & Wilm, Anal. Chem. 1994 (NLM 7843127).

Why LC-MS complements HPLC rather than replacing it

HPLC with UV detection is quantitative and reproducible but poor at establishing identity: co-eluting impurities can be invisible, and two different peptides of similar hydrophobicity can share a retention time. LC-MS flips those strengths and weaknesses. The mass spectrometer can see through a co-elution because two compounds at the same retention time will still generally show different masses, and it confirms identity by matching observed mass to theoretical mass. The two techniques are used together: HPLC establishes purity on a quantitative basis, and LC-MS confirms that the main peak is the intended sequence and profiles the chemical nature of the minor peaks (oxidation, deamidation, truncation, adduction). FDA guidance on synthetic peptide drug substances treats mass-spectrometric identity confirmation and impurity characterization as expected elements of the chemistry package (FDA ANDAs for Certain Highly Purified Synthetic Peptide Drug Substances, 2021). USP General Chapter <1736> discusses mass-spectrometric identity and impurity testing in a compendial context.

What to look for on a COA

A COA that reports LC-MS data usefully will state the observed mass (monoisotopic or average), the theoretical mass, the mass error (in ppm or Da), and ideally the ionization mode and instrument class (e.g., high-resolution Orbitrap or QTOF vs. unit-resolution quadrupole). A COA that simply states "mass confirmed" without a number is less informative. Open Assay surfaces whichever fields the underlying COA discloses and flags listings where the reported mass is missing or where the error is outside an appropriate window for the instrument class.